Aqualung Therapeutics
Aqualung Therapeutics is developing a novel, anti-inflammatory monoclonal antibody strategy to treat serious unchecked inflammation.
BioTech
$10M-25M
Funding
1-10
Employees
Looking for a better job?
Discover the best career opportunities with the best company cultures for you.
Do you work at this company?
Connect your business to thousands of engaged professionals in your city and beyond.
